compounded semaglutide telehealth us 3/7/26 The FDA just warned 30 companies about how they marketed GLP-1 weight-loss drugs online. Regulators say some companies suggested these medications were equivalent to FDA-approved drugs like Ozempic and GLP-1 receptor agonist-based therapies liveinventory Form:Capsules

compounded semaglutide telehealth us 3/7/26 The FDA just warned 30 companies about how they marketed GLP-1 weight-loss drugs online. Regulators say some companies suggested these medications were equivalent to FDA-approved drugs like Ozempic and GLP-1 receptor agonist-based therapies liveinventory Form:Capsules

GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms - PMC

Improved blood sugar regulation and metabolic health

liveinventory

Form:Capsules

And although these adverse outcomes were rare, this ‘must be considered by patients who are contemplating using the drugs for weight loss because the risk–benefit calculus for this group might differ from that of those who use them for diabetes,’ the study concluded